RP
ABEO icon

Riverwater Partners’s Abeona Therapeutics ABEO Stock Holding History

Riverwater Partners’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150K Buy
24,304
+5,238
+27% +$28.8K 0.04% 208
2026
Q1 		$85.4K Sell
19,066
-309
-2% -$1.54K 0.03% 211
2025
Q4 		$102K Buy
19,375
+3,518
+22% +$17.7K 0.04% 209
2025
Q3 		$83.7K Buy
15,857
+4,963
+46% +$31.5K 0.03% 215
2025
Q2 		$61.9K Buy
+10,894
New +$62K 0.03% 201

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Riverwater Partners's ABEO Position: Q2 2026 in Review

Riverwater Partners increased its Abeona Therapeutics (ABEO) stake by 27% in Q2 2026, buying an estimated $28.8K and bringing the position to 24,304 shares worth $150K. The position accounts for 0.04% of the portfolio, ranked #208.

Riverwater Partners first reported a position in ABEO in Q2 2025 and has held it in 5 quarters since. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Riverwater Partners held 24,304 shares of Abeona Therapeutics worth $150K as of Q2 2026.
  • Riverwater Partners bought 5,238 Abeona Therapeutics shares in Q2 2026, an estimated $28.8K.
  • Abeona Therapeutics made up 0.04% of Riverwater Partners's portfolio in Q2 2026, its #208 holding.
  • Riverwater Partners first reported a position in Abeona Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Riverwater Partners's 13F filing for Q2 2026, filed 14 Aug 2026.